Explore
Trendline
BioMarin Pharmaceutical Prepares for Earnings Report Amid Slower Revenue Growth
BioMarin Pharmaceutical Prepares for Earnings Report Amid Slower Revenue Growth
Read More
Trendline
IQVIA Exceeds Q1 Sales Estimates, Raises Full-Year Guidance
IQVIA Exceeds Q1 Sales Estimates, Raises Full-Year Guidance
Read More
Trendline
Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action
Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action
Read More
Trendline
Sarepta, Amylyx, and Neumora Prepare for Key Milestones Amidst Q1 Earnings
Sarepta, Amylyx, and Neumora Prepare for Key Milestones Amidst Q1 Earnings
Read More
Trendline
ImmunityBio Faces Securities Fraud Lawsuit Over Misleading Cancer Drug Claims
ImmunityBio Faces Securities Fraud Lawsuit Over Misleading Cancer Drug Claims
Read More
Trendline
IQVIA Anticipates Revenue Growth as Earnings Report Approaches
IQVIA Anticipates Revenue Growth as Earnings Report Approaches
Read More
Trendline
Summit Shares Plummet as Cancer Drug Fails Early Survival Benchmark
Summit Shares Plummet as Cancer Drug Fails Early Survival Benchmark
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Read More
Trendline
GameStop CEO Ryan Cohen Proposes $56 Billion Acquisition of eBay, Sparking Market Reactions
GameStop CEO Ryan Cohen Proposes $56 Billion Acquisition of eBay, Sparking Market Reactions
Read More
Reuters
Novo Nordisk's weight-loss pill boom faces price war test
By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN, May 5 (Reuters) - Novo Nordisk is seeing brisk early demand for its new weight-loss pill as competition with U.S. rival Eli Lilly intensifies.
Read More
Trendline
Traders Express Doubt Over GameStop's $55.5 Billion eBay Acquisition Bid
Traders Express Doubt Over GameStop's $55.5 Billion eBay Acquisition Bid
Read More
Trendline
Moderna Exceeds Revenue Expectations Despite Litigation Costs Impacting Earnings
Moderna Exceeds Revenue Expectations Despite Litigation Costs Impacting Earnings
Read More